{"filing":{"accession_number":"0001193125-26-253435","cik":"0001863127","ticker":"TYRA","company_name":"Tyra Biosciences, Inc.","form":"8-K","filing_date":"2026-06-02","report_date":null,"primary_document":"d33725d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526253435/d33725d8k.htm"},"events":[{"id":7458,"run_id":6554,"accession_number":"0001193125-26-253435","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 filing discloses the results of Tyra Biosciences' 2026 Annual Meeting of Stockholders held on May 28, 2026, including voting outcomes for the election of three Class II directors (Habib J. Dable, Susan Moran, and Robert More) and ratification of Ernst \u0026 Young LLP as independent auditor. The detailed vote tallies (for, withheld, against, abstentions, broker non-votes) are the core disclosure required under Item 5.07.","company_name":"Tyra Biosciences, Inc.","ticker":"TYRA","filing_date":"2026-06-02","form":"8-K","submitted_at":null,"items":[{"id":3569,"accession_number":"0001193125-26-253435","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the results of Tyra Biosciences' 2026 Annual Meeting of Stockholders held on May 28, 2026, including voting outcomes for the election of three Class II directors (Habib J. Dable, Susan Moran, and Robert More) and ratification of Ernst \u0026 Young LLP as independent auditor. The detailed vote tallies (for, withheld, against, abstentions, broker non-votes) are the core disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:16:55.369942+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3569,"accession_number":"0001193125-26-253435","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the results of Tyra Biosciences' 2026 Annual Meeting of Stockholders held on May 28, 2026, including voting outcomes for the election of three Class II directors (Habib J. Dable, Susan Moran, and Robert More) and ratification of Ernst \u0026 Young LLP as independent auditor. The detailed vote tallies (for, withheld, against, abstentions, broker non-votes) are the core disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:16:55.369942+00:00","company_name":"Tyra Biosciences, Inc.","ticker":"TYRA","filing_date":"2026-06-02"}]}